Patient tagging device for reducing medical errors gets US nod
This article was originally published in Clinica
The FDA has cleared for sale in the US a noninvasive tagging system aimed at safeguarding against surgical mishaps. The skin-mounted adhesive, called SurgiChip, is expected to remove the risk of patients being given the wrong surgical procedure or treated at the wrong site of injury. The product's Palm Beach Gardens, Florida based developer, also known as SurgiChip, says the product is the first external surgical marker to implement radiofrequency identification (RFID) technology.
You may also be interested in...
Phase I data presented at ASCO for ALLO-501 offer proof of concept for the CD19 allogeneic CAR-T and a companion drug, ALLO-647, for lymphodepletion.
Dispatches from a world turned upside down covering a possible US government investigation into BARDA contracting practices and Medicare Part D plans waiving cost sharing for COVID-19 treatments.
The US FDA requests several manufacturers recall extended-release metformin based on studies confirming a higher NDMA impurity threshhold; previous testing found no significant risks.